Delta12-prostaglandin D2 is a potent and selective CRTH2 receptor agonist and causes activation of human eosinophils and Th2 lymphocytes.

Delta12-prostaglandin D2 is a potent and selective CRTH2 receptor agonist and causes activation of human eosinophils and Th2 lymphocytes.

Prostaglandin D2 (PGD2) is a lipid mediator produced by mast cells, macrophages and Th2 lymphocytes and has been detected in high concentrations in the airways of asthmatic patients. There are two receptors for PGD2, namely the D prostanoid (DP) receptor and the chemoattractant receptor-homologous m...

Повний опис

Бібліографічні деталі
Автори:	Gazi, L, Gyles, S, Rose, J, Lees, S, Allan, C, Xue, L, Jassal, R, Speight, G, Gamble, V, Pettipher, R
Формат:	Journal article
Мова:	English
Опубліковано:	2005

Схожі ресурси

Indole-3-acetic acid antagonists of the prostaglandin D2 receptor CRTH2.
за авторством: Armer, R, та інші
Опубліковано: (2005)

Inhibition of PI3K and calcineurin suppresses chemoattractant receptor-homologous molecule expressed on Th2 cells (CRTH2)-dependent responses of Th2 lymphocytes to prostaglandin D(2).
за авторством: Xue, L, та інші
Опубліковано: (2007)

A dominant role for chemoattractant receptor-homologous molecule expressed on T helper type 2 (Th2) cells (CRTH2) in mediating chemotaxis of CRTH2+ CD4+ Th2 lymphocytes in response to mast cell supernatants.
за авторством: Gyles, S, та інші
Опубліковано: (2006)

PGH1, the precursor for the anti-inflammatory prostaglandins of the 1-series, is a potent activator of the pro-inflammatory receptor CRTH2/DP2.
за авторством: Schröder, R, та інші
Опубліковано: (2012)

Prostaglandin D2 and Interleukin-5 Reduce Crth2 Surface Expression on Human Eosinophils
за авторством: Kazuyuki Hamada, та інші
Опубліковано: (2004-01-01)

PGH1, the precursor for the anti-inflammatory prostaglandins of the 1-series, is a potent activator of the pro-inflammatory receptor CRTH2/DP2.
за авторством: Ralf Schröder, та інші
Опубліковано: (2012-01-01)

Antagonism of the prostaglandin D<sub>2 </sub>receptor CRTH2 attenuates asthma pathology in mouse eosinophilic airway inflammation
за авторством: Högberg Thomas, та інші
Опубліковано: (2007-02-01)

Prostaglandin D2 causes preferential induction of proinflammatory Th2 cytokine production through an action on chemoattractant receptor-like molecule expressed on Th2 cells.
за авторством: Xue, L, та інші
Опубліковано: (2005)

Pharmacologic profile of OC000459, a potent, selective, and orally active D prostanoid receptor 2 antagonist that inhibits mast cell-dependent activation of T helper 2 lymphocytes and eosinophils.
за авторством: Pettipher, R, та інші
Опубліковано: (2012)

Novel function of CRTH2 in preventing apoptosis of human Th2 cells through activation of the phosphatidylinositol 3-kinase pathway.
за авторством: Xue, L, та інші
Опубліковано: (2009)

Expression of DP2 (CRTh2), a prostaglandin D₂ receptor, in human mast cells.
за авторством: Tae Chul Moon, та інші
Опубліковано: (2014-01-01)

Correction: Expression of DP2 (CRTh2), a Prostaglandin D Receptor, in Human Mast Cells.
Опубліковано: (2014-01-01)

Correction: Expression of DP2 (CRTh2), a Prostaglandin D2 Receptor, in Human Mast Cells
Опубліковано: (2014-01-01)

Over-expression of CRTH2 indicates eosinophilic inflammation and poor prognosis in recurrent nasal polyps
за авторством: Wenhui Chen, та інші
Опубліковано: (2022-11-01)

CRTH2 expression on T cells in asthma.
за авторством: Mutalithas, K, та інші
Опубліковано: (2010)

CRTH2 mediates the activation of human Th2 cells in response to PGD(2) released from IgE/anti-IgE treated nasal polyp tissue.
за авторством: Pérez-Novo, C, та інші
Опубліковано: (2010)

CRTH2 antagonists in asthma: current perspectives
за авторством: Singh D, та інші
Опубліковано: (2017-12-01)

Generation and characterization of an antagonistic monoclonal antibody against an extracellular domain of mouse DP2 (CRTH2/GPR44) receptors for prostaglandin D2.
за авторством: Nanae Nagata, та інші
Опубліковано: (2017-01-01)

A randomized, double-blind, placebo-controlled study of the CRTH2 antagonist OC000459 in moderate persistent asthma.
за авторством: Barnes, N, та інші
Опубліковано: (2012)

Interaction between prostaglandin D and chemoattractant receptor-homologous molecule expressed on Th2 cells mediates cytokine production by Th2 lymphocytes in response to activated mast cells.
за авторством: Xue, L, та інші
Опубліковано: (2009)

Vasoactive Intestinal Peptide Receptor, CRTH2, Antagonist Treatment Improves Eosinophil and Mast Cell-Mediated Esophageal Remodeling and Motility Dysfunction in Eosinophilic Esophagitis
за авторством: Chandra Sekhar Yadavalli, та інші
Опубліковано: (2024-02-01)

Unravelling the roles of CRTH2+ cells in asthma pathogenesis
за авторством: Chen, W
Опубліковано: (2023)

The role of CRTH2+ CD8+ T cells in severe asthma
за авторством: Hoyle, RD
Опубліковано: (2021)

CRTH2: a potential target for the treatment of organ fibrosis
за авторством: Fan Sisi, та інші
Опубліковано: (2022-03-01)

Expression of a prostaglandin D2 receptor, CRTh2 (chemoattractant receptor-homologous molecule expressed on Th2 cells) on human mast cells and potential relevance in allergic diseases
за авторством: Moon Tae, та інші
Опубліковано: (2010-11-01)

Identification of CRTH2 as a New PPARγ-Target Gene in T Cells Suggested CRTH2 Dependent Conversion of Th2 Cells as Therapeutic Concept in COVID-19 Infection
за авторством: Becker A, та інші
Опубліковано: (2024-11-01)

Efficacy and safety of the CRTh2 antagonist AZD1981 as add-on therapy to inhaled corticosteroids and long-acting β2-agonists in patients with atopic asthma
за авторством: Bateman ED, та інші
Опубліковано: (2018-05-01)

Chemoattractant receptor homologous to the T helper 2 cell (CRTH2) is not expressed in human amniocytes and myocytes.
за авторством: Lynne Sykes, та інші
Опубліковано: (2012-01-01)

Activation of Th2 cells downregulates CRTh2 through an NFAT1 mediated mechanism.
за авторством: Emily MacLean Scott, та інші
Опубліковано: (2018-01-01)

Leukotriene E4 activates human Th2 cells for exaggerated proinflammatory cytokine production in response to prostaglandin D2.
за авторством: Xue, L, та інші
Опубліковано: (2012)

Two Phase II randomized trials on the CRTh2 antagonist AZD1981 in adults with asthma
за авторством: Kuna P, та інші
Опубліковано: (2016-08-01)

Novel nucleotide triphosphates as potent P2Y2 agonists.
за авторством: Brookings, D, та інші
Опубліковано: (2007)

QSAR study of 2,4-disubstituted phenoxyacetic acid derivatives as a CRTh2 receptor antagonists /
за авторством: Jain, Abhishek K., та інші

Synthesis and Biological Properties of Novel Fluoroprostaglandin Derivatives: Highly Selective and Potent Agonists for Prostaglandin Receptors
за авторством: Yasushi Matsumuraa, та інші
Опубліковано: (2004-03-01)

Fevipiprant, a selective prostaglandin D(2)receptor 2 antagonist, potently inhibits chemotaxis and cytokine production by Tc2 cells (type-2 CD8(+)lymphocytes)
за авторством: Xue, L, та інші
Опубліковано: (2019)

The influence of prostaglandin EP2 agonists and selected flavonoids on retinal cell death
за авторством: Kang, K
Опубліковано: (2010)

Prostaglandin D2 and leukotriene E4 synergize to stimulate diverse TH2 functions and TH2 cell/neutrophil crosstalk.
за авторством: Xue, L, та інші
Опубліковано: (2015)

CRTH2 promotes endoplasmic reticulum stress‐induced cardiomyocyte apoptosis through m‐calpain
за авторством: Shengkai Zuo, та інші
Опубліковано: (2018-01-01)

Data on the oral CRTh2 antagonist QAW039 (fevipiprant) in patients with uncontrolled allergic asthma
за авторством: Veit J. Erpenbeck, та інші
Опубліковано: (2016-12-01)

The CRTh2 polymorphism rs533116 G > A associates with asthma severity in older females
за авторством: Nami Shrestha Palikhe, та інші
Опубліковано: (2022-10-01)